Core theses · Updated 2026-11-02
Verifiability times feedback cycle sets the order; each window lasts 12 to 18 months
01The claim
The order in which AI remakes industries equals verifiability times feedback cycle: code checks itself in seconds and changes first; medicine, finance and manufacturing get feedback in months and change last; and each sector gets a 12-to-18-month window after capability crosses its threshold.
02Mechanism: why it happens
Verifiability decides where capability gets proven first, and the threshold is proven capability. A model improves by being told it is wrong; a buyer pays only after seeing the result. Where being told is free, both happen at once, and capability gets priced there first. Code passes or fails its tests in seconds and content shows clicks the same day, so those two sectors sit at the front. A diagnosis waits for the course of an illness. Being told is slow and expensive there, and however strong the model, nobody can cheaply prove it is good enough.
On September 8, 2026 Cognition announced a $2 billion Series E at a $48 billion post-money valuation (Verified, Bloomberg and Reuters); annualized revenue rose from $492 million in May to nearly $900 million (Reported), and on September 25 the company said it had passed $1 billion (Per company disclosure). Software entered its window in 2024 and is still accelerating two years later.
Feedback cycle decides how fast that proof repeats; in the formula it counts as a frequency, so a shorter cycle means a larger multiplier. With feedback in seconds a team runs tens of thousands of trials a year; in months, a handful. Three orders of magnitude in trials become three orders of magnitude in compounding. This is why knowledge work trails software by only a year: a report needs a person to judge it, so verifiability is weaker than for code, but the person judges the same day. Fast feedback compensates for weak verification.
Genspark reached $200 million ARR eleven months after launch: nine months from zero to $100 million, then a doubling in two (per company disclosure as of August 2026, unaudited; cited in the September 3, 2026 Xiamen keynote). In the SaaS era the same distance took five to seven years.
At the slow end, what jams is confirmation; capability is already sufficient. In medicine, finance and manufacturing a person or a regulator confirms the result months later, and the organization lacks a rule for when a human must look up. Until that mechanism exists, pilots stay outside the profit and loss statement, and extra capability is only extra cost. This is where FutureX Capital's first diligence question for any agent company comes from: was the human-in-the-loop mechanism designed, or skipped.
On September 8, 2026 TechTarget cited a new study finding that fewer than 1% of FDA-cleared AI medical devices have validated clinical benefit (Reported). Days earlier, STAT reported on September 3 that the FDA's TEMPO pilot had admitted generative AI devices, letting them reach patients before formal authorization (Reported). Access is loosening; the evidence gap now has a number.
The window runs 12 to 18 months because enterprise budgets run on annual cycles. In the quarter when capability crosses the threshold, only founders and early users can see it. Budgets arrive at scale in the next annual cycle, incumbents then ship the feature as a default, and regulators fill in behind. The moment the three move together, the window closes and prices return to consensus. So we date each sector at the threshold; the day budgets arrive does not count.
At its 20,000-person user meeting on August 17 to 20, 2026, Epic put AI on a platform footing, with Agent Factory offering more than 120 prebuilt AI features ahead of a 2027 general release (Verified, TechTarget and Advisory Board). The incumbent is making AI a default feature of the EHR; healthcare's window is arriving on its 2026-to-2027 date.
Robotics sits late in the order for the same reason: verification. Training data can come from human video; verification can only happen on a real machine, one trial after another. Whether a grasp worked is known only after the machine runs it, and the loop closes in days. Slow verification means no technical route can yet prove itself, while valuations have already converged. So FutureX Capital's call is that 2026 is the hardware year for humanoids and the intelligence year has not arrived; 80 points equals zero. We back dexterous hands and data and stay out of the full-body arms race.
Agility Robotics' S-4, filed with the US SEC on September 4, 2026, shows 2025 net sales of $1,781,967 against a net loss of $138,086,332, a loss about 77 times revenue (Reported, via Humanoids Daily on September 7). After years of commercial pilots, deployments have yet to convert into revenue.
03Evidence
- 01METR Time Horizon 1.1: the length of tasks AI can complete on its own doubled every 7 months from 2019 to 2025 and every 4.3 months after 2023. The curve is measured on tasks that can be verified automatically: where verification is cheap, capability is read first. (2026-01 · Verified · METR Time Horizon 1.1 (2026-01); Open Source Breaks the Deadlock slides, p. 3)
- 02Duolingo's Q2 results on August 5, 2026: revenue $298.5 million (+18%), DAU 58.7 million (+23%), and the inference cost of one AI video call down from $0.30 to under $0.01. Education measures results daily and its costs fell by the quarter; it entered its window in 2025. (2026-08-05 · Verified · Duolingo earnings; FutureX report ai-education-2026)
- 03On September 8, 2026 Cognition announced a $2 billion Series E at a $48 billion post-money valuation, close to double the $26 billion of May; annualized revenue rose from $492 million in May to nearly $900 million, and on September 25 the company said it had passed $1 billion. Software's window opened in 2024 and the revenue curve has not slowed. (2026-09-08 / 2026-09-25 · Verified (funding); Reported (ARR); Per company disclosure (September 25) · Bloomberg, Reuters, TechCrunch, Investing.com; FutureX report ai-coding-consolidation-2026)
- 04Genspark reached $200 million ARR eleven months after launch, nine months from zero to $100 million and two more to double. Knowledge work measures its result the same day, and the revenue curve tracks the feedback curve. (2026-08 · Per company disclosure · Company disclosure (as of August 2026, not independently audited); Open Source Breaks the Deadlock slides, pp. 5, 17)
- 05MIT NANDA's 2025 report: 95% of enterprise generative-AI pilots have produced no measurable P&L impact. Sufficient capability and missing confirmation coexist; that is the normal state at the slow end of the order. (2025 · Verified · MIT NANDA (2025); Open Source Breaks the Deadlock slides, p. 4)
- 06On September 3 STAT reported that the FDA's TEMPO pilot had recently admitted four devices, including generative AI products, letting them reach patients before formal authorization; on September 8 TechTarget cited a new study finding fewer than 1% of FDA-cleared AI devices have validated clinical benefit. Access is outrunning verification. (2026-09-03 / 2026-09-08 · Reported · STAT; TechTarget; FutureX report ai-healthcare-inflection-2026, ai-mental-health-2026)
- 07Agility Robotics' S-4 filed with the SEC on September 4, 2026: 2025 net sales of $1,781,967, net loss of $138,086,332, a loss about 77 times revenue; its $300 million multi-year order comes from a related-party customer. (2026-09-04 · Reported · Humanoids Daily (relayed September 7); FutureX report embodied-ai-humanoid-robots-2026)
04The strongest counterargument
Aaron Levie (Co-founder and CEO, Box), July 16, 2026, reported
After rounds with enterprise IT leaders, his conclusion: the bottleneck is change management and data readiness, and the models are already good enough; playbooks are narrowing from try-everything to roughly ten of the highest-value workflows. The strongest form: capability has crossed the threshold in most industries already, so the order is set by the buyer's capacity to change and by budget cycles. Verifiability is a property of the task; the buyer decides. The same verifiable task stalls in pilot at a company whose data is not ready.
Our reply: He is half right, and that half is already in the mechanism: in slow sectors capability is often already sufficient. What our formula ranks is the cost of proving it sufficient, and change management and data readiness are what that cost is spent on. A workflow whose result can be counted is cheap to prove, which is how it made his list of ten; one whose result cannot be counted never reaches the profit and loss statement, however much change management it gets. Inside a sector, the organization decides who deploys first; across sectors, verifiability prices the cost of proof. The two variables sit at different levels, so we rank sectors with one and pick companies with the other. If his view holds across sectors as well, see the second falsifier.
New York City Public Schools' procurement decision, September 2, 2026 (Chalkbeat New York, Verified)
Eight days before the school year, New York City announced that 2-K through grade 8 would stop using student-facing generative AI for 2026-27: AI features in 38 existing edtech contracts were switched off, the pause runs a year, and about 600,000 students, roughly two thirds of the city's enrollment, are affected. Education sits at 2025 on our timetable. The strongest form: in sectors run by public procurement, one buyer's memo can shut the window, verifiability has no say, and the procurement cycle is the real timetable.
Our reply: The buyer can delay; we accept that and count it as error. For K-12 and hospital systems a purchaser can hold the window shut for a year, and our dates carry that error bar. Something else happened the same day: McGraw Hill acquired Teachally, a five-person teacher-tools team (September 2, 2026, Per company disclosure). Procurement changed who the customer is: the student side closed while the teacher side was buying. Our dates mark the moment capability crosses the threshold; a budget delay lengthens the window and does not cancel it. If the pause spreads to most large districts, see the third falsifier.
The US FDA's pre-authorization pilot, via STAT, September 3, 2026 (Reported)
The FDA admitted four devices into its TEMPO pilot (announced in December 2025), including AI products from Cadence and Limbic, letting companies put them in front of patients before marketing authorization, after publishing a discussion paper on generative AI devices on August 18 with comments due October 19 (Verified). The strongest form: regulators are actively shortening medicine's cycle, access is outrunning evidence, and medicine may change earlier than the 2026-to-2027 date we wrote. The regulator's calendar sets the order; verifiability merely follows.
Our reply: We grant that regulation can move the date. A second number from the same week shows what it moves: fewer than 1% of FDA-cleared AI devices have validated clinical benefit (TechTarget, September 8, Reported). Looser access puts products in front of patients sooner; it does not get results judged sooner. Our date marks when vertical agents enter the profit and loss statement, and a ticket in does not count. If a regulator compresses the verification cycle itself, say by making clinical-benefit validation an automated premarket step, that is the feedback term in the formula shrinking: medicine moves earlier and the formula stands.
Jim Fan (Director of Robotics Research, NVIDIA; head of the GEAR team), May 8, 2026, confirmed
He asked the room to hold a moment of silence for teleoperation: one robot caps at 24 hours a day and yields about 3, which cannot scale. The replacement is egocentric human video plus world action models, with supply that can reach 10 million hours a year, and a physical Turing test passed within two to three years. The strongest form: the robotics bottleneck is data supply, data supply is decoupling from physical deployment and growing at internet scale, and once the reason for placing robotics late disappears, robotics jumps the queue.
Our reply: We accept the point on data supply and changed the mechanism accordingly: training data can come from video. Figure's crowdsourced platform Index had collected 16 million human videos across 108 countries and paid contributors $15 million by August 26; on September 3 Figure signed a $3.5 billion first-phase compute agreement with Nscale, with the first GPUs due online in the second half of 2027 (Reported, eWeek, September 4). That solves the learning end. The proving end is unchanged: whether a move learned from video works is known only after a real machine runs it, and that loop still closes in days. His two-to-three-year timetable lands in 2028 to 2029, which matches our call that 2026 is the hardware year and the intelligence year has not arrived. Value therefore lands on the route he describes: data and dexterous hands.
05What would change our mind
- ▸If, before June 2027, a company in healthcare, finance or manufacturing goes from zero to $100 million ARR inside 12 months while its results are still confirmed by people or regulators on a monthly cycle, the formula is wrong: feedback cycle did not constrain revenue, and we will rewrite both the dates and the ranking mechanism for those three sectors.
- ▸If a follow-up to the MIT NANDA survey shows during 2027 that the share of enterprise generative-AI pilots with no measurable P&L impact has fallen from 95% to below 50%, and those enterprises got there without outcome pricing or automated result verification, on change management alone, then Levie is right and we are wrong: organizational capacity is independent of verifiability and should be the first ranking variable.
- ▸If by September 2027 five or more of the ten largest US school districts have followed New York in pausing student-facing generative AI, and K-12 AI procurement spending is down year on year, then the procurement cycle overrode verifiability in education. We will move education off the 2025 row and list public procurement as a third variable outside the formula.
- ▸If by June 2027 GGII's count of 2026 humanoid shipments in China comes in below half its 62,500 forecast, and the leading full-body makers with disclosed financials still report under $10 million of 2026 revenue, then the 2025-to-2026 robotics and logistics row was dated too early and should move back at least a year. We will change the date in public. The reverse holds too: if before then a full-body maker turns moves learned from human video into weekly on-machine iteration and audited revenue, robotics moves earlier.
06What we do, and what we do not do
- ▸For founders: the window starts in the quarter capability crosses the threshold and lasts 12 to 18 months; once incumbents ship the feature as a default and budgets arrive at consensus prices, it is closed. Healthcare's clock is already running: Epic's Agent Factory reaches general release in 2027.
- ▸For founders: in slow-feedback sectors, healthcare, finance and manufacturing, the product has to shorten the feedback cycle: outcome pricing, result verification built into the product, ownership of the data. Plugging a model into an existing process does not reach the profit and loss statement. The first investor question will be: was the human-in-the-loop mechanism designed, or skipped.
- ▸For investors: date each sector at the moment capability crosses the threshold and enter inside the window; do not chase the tail, and stay cautious on pre-IPO rounds at 50 to 100 times sales. In robotics, look at dexterous hands and data and stay out of the full-body arms race.
- ▸For investors: screen companies on three things: distribution, retention, and whether gross margin climbs as token prices fall; for open-source projects add the path from stars to paid revenue, and Dify took about 18 months from 30,000 stars and zero revenue to $10 million ARR (Per company disclosure). Do not bet on which model wins, and stay out of debt-financed compute rental.
- ▸For investors, the signals to watch: the share of pilots with no P&L impact in follow-ups to the MIT NANDA survey (95% in 2025); whether the New York pause spreads to more large districts; and Cursor's retention curve after the cutoff. The timetable and its falsifiers are public at /answers/twelve-to-eighteen-month-window, /answers/which-industries-ai-changes-first and /debates, and dates change in public when a trigger fires. This is not investment advice.
07Open questions
- ?Does publishing a timetable of windows push prices at the tail of each window to consensus? In August 2026 SoftBank reportedly moved to buy control of 1X at about $6 billion, below the roughly $10 billion 1X sought the year before (Reported, The Information); Unitree's September 2 close was 50.4% below its opening price on debut (Public market data). Both fall inside the robotics window we dated. Whether the timetable itself is one cause of the crowding, we cannot separate out.
- ?When verification is done by another model rather than a test suite or a person, does the sector count as fast or slow? Content and knowledge work already lean on model judges. Whether they inherit the judge's speed or the judge's error rate, we do not know.
- ?Is finance one sector? Trading gets feedback in days, credit in quarters, and we wrote the whole block at 2026 to 2027. It may split into two rows more than a year apart.
- ?After the window closes, can the company that entered inside it hold its position? Epic's 2027 general release of Agent Factory is the test in healthcare; OpenAI announced on August 28, 2026 that it will stop supplying models to Cursor from November 12, and Cursor's retention curve after the cutoff is software's first answer sheet.
08Changelog
- 2026-11-02Editorial revision: the title adds the 12-to-18-month window; Cognition's September 25 run rate above $1 billion was added (per company disclosure, from our report); portfolio names removed; SoftBank's approach to 1X downgraded from verified to reported.
- 2026-09-25First published.
Related reports and answers
- Report · Agent Usage Grew Roughly 14x, but Pricing Power Goes to Data and Workflow Owners →
- Report · Healthcare AI Now Prices on Revenue: OpenEvidence's Sales Doubled, Valuation Rose Only 25% →
- Report · Humanoid Robots 2026: 100,000-Unit Guidance, but Valuations Have Run Ahead of Output →
- Report · After Chegg's 99% Fall, AI Education Value Shifts to Distribution and Guardrails →
- Which industries will AI change first? →
- What is the 12-to-18-month window in AI sectors? →
- Why do AI agents stall inside enterprises? →
- What is outcomes-as-a-service pricing? (results-as-a-service, outcome-based pricing) →
Other core theses
- Applications and open-source chokepoints hold AI's value; the model layer cannot →
- The bubble sits in the middle layer: 7-to-10-year debt on 2-to-3-year GPUs →
- The cost curve has a new author: Chinese open models at 1/40th the price →
- Models are replaceable parts; app profits rest on four moats and outcome pricing →
- 14x apart in capital, 2.7% in capability: the US and China in one cycle →
- Embodied AI: 2026 is the hardware year, and 80 points equals zero →
This essay is FutureX Capital's judgment and argument. Facts and examples come from published research, public talks, and public reporting, graded per the site-wide standard (verified / reported / per company disclosure / public market data). Judgments change with evidence; changes are logged above. Nothing here is investment advice or an offer.